CFT8919

· Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CFT8919, covering 2024-10-15 to 2024-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of CFT8919 in Patients With Advanced NSCLC [Phase 1]